News Releases

News and information from The Leukemia & Lymphoma Society

LLS Announces Expansion of Precision Medicine Approach to Fight Blood Cancer

Rye Brook, NY (July 19, 2017) – The Leukemia & Lymphoma Society (LLS) today announced the expansion of its groundbreaking precision medicine Beat AML® Master Trial, to test new, investigational treatments for acute myeloid leukemia (AML), the central initiative of LLS’s comprehensive assault on this deadly blood cancer affecting 20,000 Americans annually. Launched in October 2016, the master trial has exc...

Man & Woman of the Year is Proof Individuals can Impact Cancer Cures

View multimedia release here.  Rye Brook, NY (July 13, 2017) – As the leader in peer-to-peer fundraising for almost 70 years, The Leukemia & Lymphoma Society (LLS) continues to find ways to reinvent the way health charities raise vital funds for research and patient support. After pioneering non-profit sports training with Team In Training, LLS turned the traditional walk into a community experienc...

Senate Health Bill Puts Cancer Care Out of Reach for Many

Patients Would Face New Financial Barriers to Life-Saving Treatment Rye Brook, N.Y. (June 23, 2017) – The Senate’s Better Care Reconciliation Act would exacerbate the financial and bureaucratic barriers that stand between cancer patients and life-saving treatments, based on an analysis by The Leukemia & Lymphoma Society (LLS). Below is a statement from Louis J. DeGennaro, Ph.D.,...

LLS Helps Patients and Caregivers Find Online Support and Health Information

- LLS Community grows to nearly 5,000 users in one year -
- New collaboration with Medivizor will provide patients and caregivers with personalized, accurate and easy-to-understand medical information - Rye Brook, N.Y. (June 15, 2017) – LLS Community, a free online network providing support and education to blood cancer patients and their caregivers, launched by The Leukemia & Lymphoma Society (LLS) i...


Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: